NY State Senate Bill S2168A

Archive: Last Bill Status - Passed Senate

Introduced
In Committee
On Floor Calendar
- Passed Senate
- Passed Assembly
Delivered to Governor
Signed/Vetoed by Governor

Your Voice

Please enter your contact information

First Name *

Last Name *

Email Address *

A valid email address is required.

Home address search or enter your address manually *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Leave this field blank

Actions

view actions (16)

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Mar 26, 2018	referred to insurance delivered to assembly passed senate
Mar 05, 2018	amended on third reading 2168a
Jan 29, 2018	advanced to third reading
Jan 23, 2018	2nd report cal.
Jan 22, 2018	1st report cal.227
Jan 03, 2018	referred to insurance returned to senate died in assembly
May 15, 2017	referred to insurance delivered to assembly passed senate
May 09, 2017	ordered to third reading cal.804 committee discharged and committed to rules
Jan 12, 2017	referred to insurance

Votes

Bill Amendments

Original

A (Active)

Original

A (Active)

Co-Sponsors

view additional co-sponsors

S2168 - Details

Current Committee:: Assembly Insurance
Law Section:: Insurance Law
Laws Affected:: Amd §213, Ins L
Versions Introduced in Other Legislative Sessions:: 2015-2016: S7777
2019-2020: S1345
2021-2022: S3753

S2168 - Summary

Requires the New York state health care quality and cost containment commission to issue a report considering the impact on health insurance costs and quality of legislation requiring coverage of long term and chronic Lyme disease and other tick-borne diseases.

S2168 - Sponsor Memo

 BILL NUMBER:  S2168

 TITLE OF BILL :  An act to amend the insurance law, in relation to
meetings and reports of the New York state health care quality and
cost containment commission

 PURPOSE :

To require the New York State Health Care Quality and Cost Containment
Commission to meet each year, and to submit a report on the impact of
providing insurance coverage for Lyme and other tick-borne related
diseases.

 SUMMARY OF PROVISIONS :

Section 1: Requires the commission to meet on the first Monday after
the first of January of each year to consider any outstanding requests
or duties. Also requires that the commission submits a report to the
governor and legislature which considers the impact on health
insurance costs of requiring coverage of Lyme and other tick-borne
diseases by May 1, 2018.

Section 2: Provides the effective date.

 JUSTIFICATION :

Currently, health insurance companies are not required to cover long
term treatment for those who suffer from chronic Lyme or other related
diseases, and for many New Yorkers, this is devastating.  Those
suffering from chronic Lyme can experience extreme fatigue, nausea,
depression, joint pain and many other symptoms.  Massachusetts, Rhode
Island and Connecticut have recognized the toll these diseases take on
victims by passing legislation which requires that Lyme disease be
covered by insurance.

This bill is the first major step in establishing a conversation on
what can be done to address this issue in New York and figuring out
what a solution would look like. No individual should be left with the
choice of covering the exorbitant costs needed to combat Lyme disease
or sacrificing their quality of life because they cannot afford the
necessary treatment.

 LEGISLATIVE HISTORY :

2016: S.7777 Passed Senate

 FISCAL IMPLICATIONS :

None.   EFFECTIVE DATE :
This act shall take effect immediately.

S2168 - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  2168

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                            January 12, 2017
                               ___________

Introduced  by  Sen.  SERINO -- read twice and ordered printed, and when
  printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law, in relation to meetings  and  reports
  of the New York state health care quality and cost containment commis-
  sion

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 213 of the insurance law, as added by section 1  of
part L of chapter 57 of the laws of 2007, is amended to read as follows:
  § 213. New York state health care quality and cost containment commis-
sion.  (a)  There  is hereby established within the department a commis-
sion, to be known as the "New York state health care  quality  and  cost
containment  commission".  The  commission  shall  consist  of  thirteen
members appointed by the governor, one of whom shall be the  superinten-
dent,  one  of whom shall be the commissioner of health, and six of whom
shall be appointed on the recommendation of the legislative leaders, two
on the recommendation of the temporary president of the senate,  two  on
the  recommendation of the speaker of the assembly, one on the recommen-
dation of the minority leader of the senate, and one on the  recommenda-
tion  of the minority leader of the assembly. All members shall serve at
the pleasure of the governor, and vacancies shall be  appointed  in  the
same  manner  as  original appointments. Members of the commission shall
serve without compensation, but shall be reimbursed for reasonable trav-
el expenses. In making appointments  to  the  commission,  the  governor
shall  ensure  that  the interests of health care consumers, small busi-
nesses, the medical community and health plans are  represented  on  the
commission.    THE  COMMISSION  SHALL  BE  REQUIRED TO MEET ON THE FIRST
MONDAY AFTER THE FIRST OF JANUARY OF  EACH  CALENDAR  YEAR  TO  CONSIDER
OUTSTANDING REQUESTS OR DUTIES.  ANY VACANCIES SHALL BE DEEMED WAIVED BY
THE  APPOINTING AUTHORITY FOR THE PURPOSES OF THE FIRST MEETING. NOTHING

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD04853-01-7

S. 2168                             2

IN THIS SECTION SHALL FORFEIT THE RIGHT FOR AN APPOINTMENT AUTHORITY  TO
FILL VACANCIES WITHIN THEIR STATUTORILY ALLOWED MEMBERS.
  (b)(1) The purpose of the commission shall be to analyze the impact on
health  insurance  costs and quality of proposed legislation which would
mandate that health benefits be offered or made available in  individual
and  group health insurance policies, contracts and comprehensive health
service plans, including legislation that affects the delivery of health
benefits or services or the reimbursement of health care providers.
  (2) [The] NOTWITHSTANDING ANY OTHER PROVISION OF  LAW,  THE  governor,
the  chair of the senate insurance committee and the chair of the assem-
bly insurance committee may request in writing that the commission eval-
uate a proposed mandated benefit. Upon receiving  such  a  request,  the
commission  may,  by a majority vote of its members, undertake an evalu-
ation of such proposed mandated benefit.
  (3) In evaluating a proposed mandated benefit, the commission shall:
  (A) investigate the current practices of health plans with  regard  to
the  proposed mandated benefit, and, to the extent possible, self-funded
health benefit plans;
  (B) investigate the potential premium impact of the proposed  mandated
benefits  on all segments of the insurance market, as well as the poten-
tial for avoided costs through early detection and treatment  of  condi-
tions, or more cost-effective delivery of medical services; and
  (C) analyze the most current medical literature regarding the proposed
mandated benefit to determine its impact on health care quality.
  (4) In evaluating a proposed mandated benefit, the commission may hold
one  or more public hearings, and shall strive to obtain independent and
verifiable information from diverse sources within the healthcare indus-
try, medical community and among health care consumers  with  regard  to
the proposed mandated benefit.
  (c)  To assist the commission in its duties, and upon the direction of
the commission, the superintendent is authorized to enter  into  one  or
more  contracts  with independent entities and organizations with demon-
strable expertise in health care quality, finance, utilization and actu-
arial services. For the purposes of  this  section,  the  superintendent
shall  not enter into contracts with health plans, entities or organiza-
tions owned or controlled by health plans, or with significant  business
relationships with health plans.
  (d)  Upon  completion of its evaluation of a proposed mandated benefit
pursuant to this section, the commission shall deliver a written  report
of its findings to the chair of the assembly insurance committee and the
chair of the senate insurance committee.
  (E)  THE COMMISSION SHALL ISSUE A REPORT TO THE GOVERNOR, THE MAJORITY
LEADER OF THE SENATE, THE SPEAKER OF THE ASSEMBLY,  THE  CHAIRS  OF  THE
SENATE  AND  ASSEMBLY  INSURANCE COMMITTEES, AND THE CHAIR OF THE SENATE
TASK FORCE ON LYME AND TICK-BORNE DISEASES, CONSIDERING  THE  IMPACT  ON
HEALTH  INSURANCE COSTS AND QUALITY OF LEGISLATION REQUIRING COVERAGE OF
LONG-TERM AND CHRONIC LYME DISEASE AND OTHER  TICK-BORNE  DISEASES.  THE
COMMISSION  SHALL  BE  REQUIRED  TO  CONSIDER  ISSUES INCLUDING, BUT NOT
LIMITED TO, THE SPECIFIC MEDICAL IMPACTS TO PARTICULAR GEOGRAPHIC  AREAS
IN THE STATE INCLUDING THE HUDSON VALLEY AND LONG ISLAND, BEST PRACTICES
DEVELOPED  FOR  COVERAGE FOR LONG-TERM AND CHRONIC LYME DISEASE IN OTHER
STATES, AND THE ASSOCIATED COSTS OF MANDATED  COVERAGE  IN  ADDITION  TO
PROJECTED  COSTS  OF UNTREATED SYMPTOMS.  THE COMMISSION SHALL DELIVER A
WRITTEN REPORT OF ITS FINDINGS BY MAY FIRST, TWO THOUSAND EIGHTEEN.
  § 2. This act shall take effect immediately.

Co-Sponsors

view additional co-sponsors

S2168A (ACTIVE) - Details

Current Committee:: Assembly Insurance
Law Section:: Insurance Law
Laws Affected:: Amd §213, Ins L
Versions Introduced in Other Legislative Sessions:: 2015-2016: S7777
2019-2020: S1345
2021-2022: S3753

S2168A (ACTIVE) - Summary

S2168A (ACTIVE) - Sponsor Memo

 
BILL NUMBER: S2168A

SPONSOR: SERINO
 
TITLE OF BILL:  An act to amend the insurance law, in relation to
meetings and reports of the New York state health care quality and cost
containment commission

 
PURPOSE:

To require the New York State Health Care Quality and Cost Containment
Commission to meet each year, and to submit a report on the impact of
providing insurance coverage for Lyme and other tick-borne related
diseases.

 
SUMMARY OF PROVISIONS:

Section 1: Requires the commission to meet on the first Monday after the
first of January of each year to consider any outstanding requests or
duties. Also requires that the commission submits a report to the gover-
nor and legislature which considers the impact on health insurance costs
of requiring coverage of Lyme and other tick-borne diseases by May 1,

2019.

Section 2: Provides the effective date.

 
JUSTIFICATION:

Currently, health insurance companies are not required to cover long
term treatment for those who suffer from chronic Lyme or other related
diseases, and for many New Yorkers, this is devastating.  Those suffer-
ing from chronic Lyme can experience extreme fatigue, nausea,
depression, joint pain and many other symptoms.  Massachusetts, Rhode
Island and Connecticut have recognized the toll these diseases take on
victims by passing legislation, which requires that Lyme disease be
covered by insurance.

This bill is the first major step in establishing a conversation on what
can be done to address this issue in New York and figuring out what a
solution would look like. No individual should be left with the choice
of covering the exorbitant costs needed to combat Lyme disease or sacri-
ficing their quality of life because they cannot afford the necessary
treatment.

 
LEGISLATIVE HISTORY:

2016: S.7777 Passed Senate
2017: S.168 Passed Senate

 
FISCAL IMPLICATIONS:

None.

 
EFFECTIVE DATE:
This act shall take effect immediately.

S2168A (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 2168--A
    Cal. No. 227

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                            January 12, 2017
                               ___________

Introduced  by  Sens.  SERINO, AKSHAR, HELMING, JACOBS, KENNEDY, LARKIN,
  MARCHIONE, O'MARA, RITCHIE, VALESKY -- read twice and ordered printed,
  and when printed to be committed to  the  Committee  on  Insurance  --
  recommitted  to  the  Committee on Insurance in accordance with Senate
  Rule 6, sec. 8 -- reported favorably from said committee,  ordered  to
  first  and  second  report,  ordered  to  a third reading, amended and
  ordered reprinted, retaining its place in the order of third reading

AN ACT to amend the insurance law, in relation to meetings  and  reports
  of the New York state health care quality and cost containment commis-
  sion

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 213 of the insurance law, as added by section 1  of
part L of chapter 57 of the laws of 2007, is amended to read as follows:
  § 213. New York state health care quality and cost containment commis-
sion.  (a)  There  is hereby established within the department a commis-
sion, to be known as the "New York state health care  quality  and  cost
containment  commission".  The  commission  shall  consist  of  thirteen
members appointed by the governor, one of whom shall be the  superinten-
dent,  one  of whom shall be the commissioner of health, and six of whom
shall be appointed on the recommendation of the legislative leaders, two
on the recommendation of the temporary president of the senate,  two  on
the  recommendation of the speaker of the assembly, one on the recommen-
dation of the minority leader of the senate, and one on the  recommenda-
tion  of the minority leader of the assembly. All members shall serve at
the pleasure of the governor, and vacancies shall be  appointed  in  the
same  manner  as  original appointments. Members of the commission shall
serve without compensation, but shall be reimbursed for reasonable trav-
el expenses. In making appointments  to  the  commission,  the  governor
shall  ensure  that  the interests of health care consumers, small busi-
nesses, the medical community and health plans are  represented  on  the
commission.    THE  COMMISSION  SHALL  BE  REQUIRED TO MEET ON THE FIRST
MONDAY AFTER THE FIRST OF JANUARY OF  EACH  CALENDAR  YEAR  TO  CONSIDER

OUTSTANDING REQUESTS OR DUTIES.  ANY VACANCIES SHALL BE DEEMED WAIVED BY

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD04853-04-8

S. 2168--A                          2

THE  APPOINTING AUTHORITY FOR THE PURPOSES OF THE FIRST MEETING. NOTHING
IN THIS SECTION SHALL FORFEIT THE RIGHT FOR AN APPOINTMENT AUTHORITY  TO
FILL VACANCIES WITHIN THEIR STATUTORILY ALLOWED MEMBERS.
  (b)(1) The purpose of the commission shall be to analyze the impact on
health  insurance  costs and quality of proposed legislation which would
mandate that health benefits be offered or made available in  individual
and  group health insurance policies, contracts and comprehensive health
service plans, including legislation that affects the delivery of health
benefits or services or the reimbursement of health care providers.
  (2) [The] NOTWITHSTANDING ANY OTHER PROVISION OF  LAW,  THE  governor,
the  chair of the senate insurance committee and the chair of the assem-
bly insurance committee may request in writing that the commission eval-
uate a proposed mandated benefit. Upon receiving  such  a  request,  the
commission  may,  by a majority vote of its members, undertake an evalu-
ation of such proposed mandated benefit.
  (3) In evaluating a proposed mandated benefit, the commission shall:
  (A) investigate the current practices of health plans with  regard  to
the  proposed mandated benefit, and, to the extent possible, self-funded
health benefit plans;
  (B) investigate the potential premium impact of the proposed  mandated
benefits  on all segments of the insurance market, as well as the poten-
tial for avoided costs through early detection and treatment  of  condi-
tions, or more cost-effective delivery of medical services; and
  (C) analyze the most current medical literature regarding the proposed
mandated benefit to determine its impact on health care quality.
  (4) In evaluating a proposed mandated benefit, the commission may hold
one  or more public hearings, and shall strive to obtain independent and
verifiable information from diverse sources within the healthcare indus-
try, medical community and among health care consumers  with  regard  to
the proposed mandated benefit.
  (c)  To assist the commission in its duties, and upon the direction of
the commission, the superintendent is authorized to enter  into  one  or
more  contracts  with independent entities and organizations with demon-
strable expertise in health care quality, finance, utilization and actu-
arial services. For the purposes of  this  section,  the  superintendent
shall  not enter into contracts with health plans, entities or organiza-
tions owned or controlled by health plans, or with significant  business
relationships with health plans.
  (d)  Upon  completion of its evaluation of a proposed mandated benefit
pursuant to this section, the commission shall deliver a written  report
of its findings to the chair of the assembly insurance committee and the
chair of the senate insurance committee.
  (E)  THE COMMISSION SHALL ISSUE A REPORT TO THE GOVERNOR, THE MAJORITY
LEADER OF THE SENATE, THE SPEAKER OF THE ASSEMBLY,  THE  CHAIRS  OF  THE
SENATE  AND  ASSEMBLY  INSURANCE COMMITTEES, AND THE CHAIR OF THE SENATE
TASK FORCE ON LYME AND TICK-BORNE DISEASES, CONSIDERING  THE  IMPACT  ON
HEALTH  INSURANCE COSTS AND QUALITY OF LEGISLATION REQUIRING COVERAGE OF
LONG-TERM AND CHRONIC LYME DISEASE AND OTHER  TICK-BORNE  DISEASES.  THE
COMMISSION  SHALL  BE  REQUIRED  TO  CONSIDER  ISSUES INCLUDING, BUT NOT
LIMITED TO, THE SPECIFIC MEDICAL IMPACTS TO PARTICULAR GEOGRAPHIC  AREAS
IN THE STATE INCLUDING THE HUDSON VALLEY AND LONG ISLAND, BEST PRACTICES
DEVELOPED  FOR  COVERAGE FOR LONG-TERM AND CHRONIC LYME DISEASE IN OTHER
STATES, AND THE ASSOCIATED COSTS OF MANDATED  COVERAGE  IN  ADDITION  TO
PROJECTED  COSTS  OF UNTREATED SYMPTOMS.  THE COMMISSION SHALL DELIVER A
WRITTEN REPORT OF ITS FINDINGS BY MAY FIRST, TWO THOUSAND NINETEEN.
  § 2. This act shall take effect immediately.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.

The New York State Senate

senate Bill S2168A

Sponsored By

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

Mar 26, 2018 - floor Vote

Floor Vote: Mar 26, 2018

Jan 22, 2018 - Insurance committee Vote

Committee Vote: Jan 22, 2018

May 15, 2017 - floor Vote

Floor Vote: May 15, 2017

May 9, 2017 - Rules committee Vote

Committee Vote: May 9, 2017

Bill Amendments

Co-Sponsors

S2168 - Details

S2168 - Summary

S2168 - Sponsor Memo

S2168 - Bill Text download pdf

Co-Sponsors

S2168A (ACTIVE) - Details

S2168A (ACTIVE) - Summary

S2168A (ACTIVE) - Sponsor Memo

S2168A (ACTIVE) - Bill Text download pdf

Comments

senate Bill S2168A

Share this bill

Sponsored By

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

Mar 26, 2018 - floor Vote

Floor Vote: Mar 26, 2018

Jan 22, 2018 - Insurance committee Vote

Committee Vote: Jan 22, 2018

May 15, 2017 - floor Vote

Floor Vote: May 15, 2017

May 9, 2017 - Rules committee Vote

Committee Vote: May 9, 2017

Bill Amendments

Co-Sponsors

S2168 - Details

S2168 - Summary

S2168 - Sponsor Memo

S2168 - Bill Text download pdf

Co-Sponsors

S2168A (ACTIVE) - Details

S2168A (ACTIVE) - Summary

S2168A (ACTIVE) - Sponsor Memo

S2168A (ACTIVE) - Bill Text download pdf

Comments